Selfish spermatogonial selection: Evidence from an immunohistochemical screen in testes of elderly men

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Lim, Jasmine ^a,d   Maher, Geoffrey J ^a   Turner, Gareth D H ^b,e   Dudka Ruszkowska, Wioleta ^a,f   Taylor, Stephen ^a   Meyts, Ewa Rajpert De ^c   Goriely, Anne ^a   Wilkie, Andrew O M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF MALAYA   (Malaysia)

^e MAHIDOL UNIVERSITY   (Thailand)

^f NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; PROTEIN KINASE B;

AGED; AGING; ARTICLE; CELL AGGREGATION; CELL EXPANSION; CELL MUTANT; CELL POPULATION; CELLULAR DISTRIBUTION; DNA EXTRACTION; GENE CLUSTER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MUTATION; PREDICTION; SELFISH SPERMATOGONIAL SELECTION; SEMINIFEROUS TUBULE; SEMINOMA; SIGNAL TRANSDUCTION; SPERMATOGONIUM; TESTIS; TISSUE SECTION;

AGED; ANTIGENS; ANTIGENS, NEOPLASM; CLONE CELLS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MODELS, BIOLOGICAL; MUTATION; NEOPLASM PROTEINS; SEMINIFEROUS TUBULES; SPERMATOGONIA; TESTIS;

EID: 84864644667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042382     Document Type: Article

References (66)

1. Moloney DM, Slaney SF, Oldridge M, Wall SA, Sahlin P, et al. ((1996)) Exclusive paternal origin of new mutations in Apert syndrome. Nat Genet 13:48-53.
2. Wilkin DJ, Szabo JK, Cameron R, Henderson S, Bellus GA, et al. ((1998)) Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet 63:711-716.
3. Sol-Church K, Stabley DL, Nicholson L, Gonzalez IL, Gripp KW, ((2006)) Paternal bias in parental origin of HRAS mutations in Costello syndrome. Hum Mutat 27:736-741.
4. Tartaglia M, Cordeddu V, Chang H, Shaw A, Kalidas K, et al. ((2004)) Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. Am J Hum Genet 75:492-497.
5. Carlson KM, Bracamontes J, Jackson CE, Clark R, Lacroix A, et al. ((1994)) Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet 55:1076-1082.
6. Goriely A, Wilkie AOM, ((2012)) Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am J Hum Genet 90:175-200.
7. Goriely A, McVean GA, Rojmyr M, Ingemarsson B, Wilkie AOM, ((2003)) Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 301:643-646.
8. Goriely A, McVean GA, van Pelt AM, O'Rourke AW, Wall SA, et al. ((2005)) Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc Natl Acad Sci U S A 102:6051-6056.
9. Yoon SR, Qin J, Glaser RL, Jabs EW, Wexler NS, et al. ((2009)) The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect. PLoS Genet 5:e1000558.
10. Tiemann-Boege I, Navidi W, Grewal R, Cohn D, Eskenazi B, et al. ((2002)) The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect. Proc Natl Acad Sci U S A 99:14952-14957.
11. Goriely A, Hansen RM, Taylor IB, Olesen IA, Jacobsen GK, et al. ((2009)) Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet 41:1247-1252.
12. Goriely A, McGowan SJ, Pfeifer SP, Itani A, McVean GAT, et al. ((2011)) The effects of advanced paternal age on genetic risks are mediated through dysregulation of HRAS signalling in the testis. 12th International Congress of Human Genetics (ICHG2011). Montreal, Canada. 44, abstract 114.
13. Oosterhuis JW, Looijenga LH, ((2005)) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210-222.
14. Eble JN, ((1994)) Spermatocytic seminoma. Hum Pathol 25:1035-1042.
15. Lim J, Goriely A, Turner GD, Ewen KA, Jacobsen GK, et al. ((2011)) OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia. J Pathol 224:473-483.
16. Rajpert-De Meyts E, ((2007)) Recent advances and future directions in research on testicular germ cell cancer. Int J Androl 30:192-197.
17. Waheeb R, Hofmann MC, ((2011)) Human spermatogonial stem cells: a possible origin for spermatocytic seminoma. Int J Androl 34:e296-305.
18. Kubota H, Avarbock MR, Brinster RL, ((2004)) Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells. Proc Natl Acad Sci U S A 101:16489-16494.
19. Lee J, Kanatsu-Shinohara M, Morimoto H, Kazuki Y, Takashima S, et al. ((2009)) Genetic reconstruction of mouse spermatogonial stem cell self-renewal in vitro by Ras-cyclin D2 activation. Cell Stem Cell 5:76-86.
20. Qin J, Calabrese P, Tiemann-Boege I, Shinde DN, Yoon SR, et al. ((2007)) The molecular anatomy of spontaneous germline mutations in human testes. PLoS Biol 5:e224.
21. Choi SK, Yoon SR, Calabrese P, Arnheim N, ((2008)) A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations. Proc Natl Acad Sci U S A 105:10143-10148.
22. Choi S-K, Yoon S-R, Calabrease P, Arnheim N, ((2012)) Positive Selection for New Disease Mutations in the Human Germline: Evidence from the Heritable Cancer Syndrome Multiple Endocrine Neoplasia Type 2B. PLoS Genetics 8:e1002420.
23. Crow JF, ((2006)) Age and sex effects on human mutation rates: an old problem with new complexities. J Radiat Res (Tokyo) 47 Suppl B. pp. B75-82.
24. Dakouane Giudicelli M, Serazin V, Le Sciellour CR, Albert M, Selva J, et al. ((2008)) Increased achondroplasia mutation frequency with advanced age and evidence for G1138A mosaicism in human testis biopsies. Fertil Steril 89:1651-1656.
25. Glass J, ((2005)) Testes and epididymes. In: Standring S, editor. Gray's Anatomy: The anatomical basis of clinical practice (39th ed.). Edinburgh: Elsevier Churchill Livingston. pp. 1304-1310.
26. Clermont Y, ((1963)) The cycle of the seminiferous epithelium in man. Am J Anat 112:35-51.
27. Amann RP, ((2008)) The cycle of the seminiferous epithelium in humans: a need to revisit? J Androl 29:469-487.
28. Holstein AF, Bustos-Obregon E, Hartmann M, ((1984)) Dislocated type-A spermatogonia in human seminiferous tubules. Cell Tissue Res 236:35-40.
29. Bergmann M, Nashan D, Nieschlag E, ((1989)) Pattern of compartmentation in human seminiferous tubules showing dislocation of spermatogonia. Cell Tissue Res 256:183-190.
30. Lindner SG, ((1982)) On the morphology of the transitional zone of the seminiferous tubule and the rete testis in man. Andrologia 14:352-362.
31. Pop OT, Cotoi CG, Plesea IE, Gherghiceanu M, Enache SD, et al. ((2011)) Histological and ultrastructural analysis of the seminiferous tubule wall in ageing testis. Rom J Morphol Embryol 52:241-248.
32. Sato Y, Nozawa S, Iwamoto T, ((2008)) Study of spermatogenesis and thickening of lamina propria in the human seminiferous tubules. Fertil Steril 90:1310-1312.
33. Muller J, Skakkebaek NE, Parkinson MC, ((1987)) The spermatocytic seminoma: views on pathogenesis. Int J Androl 10:147-156.
34. Johnson L, ((1986)) Spermatogenesis and aging in the human. J Androl 7:331-354.
35. Nistal M, Codesal J, Paniagua R, Santamaria L, ((1987)) Decrease in the number of human Ap and Ad spermatogonia and in the Ap/Ad ratio with advancing age. New data on the spermatogonial stem cell. J Androl 8:64-68.
36. Paniagua R, Nistal M, Sáez F, Fraile B, ((1991)) Ultrastructure of the aging human testis. J Electron Microsc Tech 19:241-301.
37. Berglund L, Bjorling E, Oksvold P, Fagerberg L, Asplund A, et al. ((2008)) A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics 7:2019-2027.
38. Johnsen SG, ((1970)) Testicular biopsy score count-a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Hormones 1:2-25.
39. Behre HM, Nashan D, Nieschlag E, ((1989)) Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. Int J Androl 12:395-403.
40. Tan KH, Lim PH, ((1991)) Testicular biopsy and scrotal exploration in the management of male infertility. Singapore Med J 32:41-46.
41. McLachlan RI, Rajpert-De Meyts E, Hoei-Hansen CE, de Kretser DM, Skakkebaek NE, ((2007)) Histological evaluation of the human testis-approaches to optimizing the clinical value of the assessment: Mini Review. Hum Reprod 22:2-16.
42. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, et al. ((2008)) European Consensus Conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I. Eur Urol. 53:478-496.
43. Lee J, Kanatsu-Shinohara M, Inoue K, Ogonuki N, Miki H, et al. ((2007)) Akt mediates self-renewal division of mouse spermatogonial stem cells. Development 134:1853-1859.
44. Klein AM, Nakagawa T, Ichikawa R, Yoshida S, Simons BD, ((2010)) Mouse germ line stem cells undergo rapid and stochastic turnover. Cell Stem Cell 7:214-224.
45. Ventela ST, Makela JA, Kulmala J, Westermarck J, Toppari J, ((2012)) Identification and Regulation of a Stage-Specific Stem Cell Niche Enriched by Nanog Positive Spermatogonial Stem Cells in the Mouse Testis. Stem Cells.
46. Ren ZP, Hedrum A, Ponten F, Nister M, Ahmadian A, et al. ((1996)) Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 12:765-773.
47. Ren ZP, Ahmadian A, Ponten F, Nister M, Berg C, et al. ((1997)) Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. Am J Pathol 150:1791-1803.
48. Park SY, Gonen M, Kim HJ, Michor F, Polyak K, ((2010)) Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest 120:636-644.
49. Chang H, Stewart AK, Qi XY, Li ZH, Yi QL, et al. ((2005)) Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma. Blood 106:353-355.
50. Tomlinson DC, Baldo O, Harnden P, Knowles MA, ((2007)) FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer. J Pathol 213:91-98.
51. Poynter JN, Siegmund KD, Weisenberger DJ, Long TI, Thibodeau SN, et al. ((2008)) Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev 17:3208-3215.
52. Marcar L, Maclaine NJ, Hupp TR, Meek DW, ((2010)) Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin. Cancer Res 70:10362-10370.
53. Zhu X, Asa SL, Ezzat S, ((2010)) Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer. Am J Pathol 176:2333-2343.
54. Rimoldi D, Salvi S, Schultz-Thater E, Spagnoli GC, Cerottini JC, ((2000)) Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family. Int J Cancer 86:749-751.
55. Martinez-Torrecuadrada JL, Cheung LH, Lopez-Serra P, Barderas R, Canamero M, et al. ((2008)) Antitumor activity of fibroblast growth factor receptor 3-specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis. Mol Cancer Ther 7:862-873.
56. Khnykin D, Troen G, Berner JM, Delabie J, ((2006)) The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma. J Pathol 208:431-438.
57. Johnston CL, Cox HC, Gomm JJ, Coombes RC, ((1995)) Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J Biol Chem 270:30643-30650.
58. Tan PH, Bay BH, Yip G, Selvarajan S, Tan P, et al. ((2005)) Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death. Mod Pathol 18:374-381.
59. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, et al. ((1984)) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715.
60. Landry C, Brasseur F, Spagnoli GC, Marbaix E, Boon T, et al. ((2000)) Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int J Cancer 86:835-841.
61. Aubry F, Satie AP, Rioux-Leclercq N, Rajpert-De Meyts E, Spagnoli GC, et al. ((2001)) MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer 92:2778-2785.
62. Al-Saad S, Donnem T, Al-Shibli K, Persson M, Bremnes RM, et al. ((2009)) Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer. Anticancer Res 29:4175-4183.
63. Kimura T, Tomooka M, Yamano N, Murayama K, Matoba S, et al. ((2008)) AKT signaling promotes derivation of embryonic germ cells from primordial germ cells. Development 135:869-879.
64. Gori S, Sidoni A, Colozza M, Ferri I, Mameli MG, et al. ((2009)) EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab. Ann Oncol 20:648-654.
65. dos Santos NR, Torensma R, de Vries TJ, Schreurs MW, de Bruijn DR, et al. ((2000)) Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res 60:1654-1662.
66. Stoop H, van Gurp R, de Krijger R, Geurts van Kessel A, Koberle B, et al. ((2001)) Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: diagnostic and etiological implications. Lab Invest 81:919-928.